For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Anti-Aging & Longevity · Comparison

SS-31 vs Thymalin

A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

SS-31Thymalin
CategoryAnti-Aging & LongevityAnti-Aging & Longevity
Also known asElamipretide, MTP-131, Bendavia, Szeto-Schiller peptide 31thymic peptide bioregulator, T-activin extract, thymus peptide, thymic bioregulator
EvidenceInvestigational (in trials)Research-stage
Dosing range1mg–10mg mg, daily or every other day5mg–20mg mg, 5–10 day course, 1–2x per year
AdministrationSubcutaneous injection, Intravenous (clinical trials)Intramuscular injection, Subcutaneous injection
Key side effectsInjection site reactions, Nausea (rare), Generally well-tolerated in clinical trial populationsInjection site reactions, Mild fever (rare), Temporary increase in immune activity (desired response), Rare hypersensitivity
Cited sources2 references2 references

Key differences

  • Evidence level differs: SS-31 is investigational (in trials), while Thymalin is research-stage.
  • Administration: SS-31 — Subcutaneous injection, Intravenous (clinical trials); Thymalin — Intramuscular injection, Subcutaneous injection.
  • Frequency: SS-31 is typically daily or every other day; Thymalin is 5–10 day course, 1–2x per year.

How each works

SS-31

SS-31 selectively accumulates in mitochondria and binds cardiolipin — a phospholipid critical for the electron transport chain. By stabilizing cardiolipin, SS-31 restores ATP production, reduces reactive oxygen species (ROS), and prevents mitochondrial permeability transition. Animal studies show dramatic reversal of mitochondrial dysfunction in aged tissues.

Thymalin

Thymalin contains multiple bioactive peptides that stimulate T-lymphocyte differentiation and restore thymic function that declines with age. In Khavinson's 6-year controlled trial of elderly patients (78–89 years), annual thymalin courses were associated with significantly lower mortality and improved immune parameters vs. controls. Proposed mechanisms include telomerase activation in immune cells and restoration of thymic epithelial cell function.

Read the full SS-31 profileRead the full Thymalin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.